APOE and Alzheimer disease: Clinically, early indicators of insulin resistance, such as elevated triglyceride-glucose (TyG) index, predict accelerated cognitive decline and Aβ accumulation in presymptomatic stages in AD patients independent of genetic risk (e.g., APOE ε4), suggesting metabolic factors exacerbate amyloid pathology via IDE-linked pathways [73].